AVADEL PHARMACEUTICALS (AVDL) Stock Income Statement
USA - NASDAQ:AVDL - IE00BDGMC594 - Common Stock
23.56 USD
+4.32 (+22.45%)
23.12 USD
-0.44 (-1.87%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 248.52M | 169.12M | 27.96M | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | 22.14M | 15.28M | 846.00K | null | 0 | |||
| Gross Profit | 226.38M | 153.84M | 27.12M | null | 0 | |||
| Operating Expenses | 231.35M | 196.24M | 164.97M | 95.22M | 85.60M | |||
| Research and Development | 39.89M | 15.20M | 13.26M | 20.70M | 17.10M | |||
| Selling, General, and Administrative Expenses | 191.46M | 181.04M | 151.71M | 74.52M | 68.50M | |||
| Operating Income | -4.98M | -42.40M | -137.85M | -95.22M | -85.60M | |||
| Interest Income/Expense | -9.71M | -10.83M | -9.89M | -12.34M | -9.94M | |||
| Other Income/Expense | 1.93M | 4.15M | 87.00K | -536.00K | 2.34M | |||
| Non Recurring Items | null | 0 | -13.13M | -3.35M | 53.00K | |||
| Income Before Taxes | -3.26M | -49.08M | -160.78M | -111.44M | -93.14M | |||
| Income Tax | -2.98M | -247.00K | -501.00K | 26.02M | -15.82M | |||
| Net Income | -278.00K | -48.83M | -160.28M | -137.46M | -77.33M | |||
| EBITDA | -1.30M | -39.72M | -136.08M | -93.72M | -84.78M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.0061496627179085245 | -0.5739312496549897 | -2.236240988330371 | -2.5604959316382745 | -1.4759190522980448 | |||
| Non GAAP EPS | 0 | -0.52 | -2.01 | -2.25 | -1.32 | |||
| Statistics | ||||||||
| Gross Profit Margin | 91.09% | 90.97% | 96.97% | N/A | N/A | |||
| Profit Margin | -0.11% | -28.87% | -573.17% | N/A | N/A | |||
| Operating Profit Margin | -2.00% | -25.07% | -492.97% | N/A | N/A | |||
All data in USD